Federal Register Notice: FDA will hold a public meeting 7/27-28 to obtain input on issues and challenges associated with developing and implementing risk evaluation and mitigation strategies (REMS) for drugs and biological products. The meeting will be held from 8:30 a.m. to 4:30 p.m. at FDA's White Oak Campus, 10903 New Hampshire Ave., Bldg. 31, Rm. 1503, Silver Spring, MD 20993. Contact Kristen Everett, (301) 796- 0453. To view this notice, click here.
